Go Pro
NASDAQ:AFJK

Aimei Health Technology (AFJK) Stock Price, News & Analysis

Aimei Health Technology logo
$12.52 +0.53 (+4.38%)
Closing price 03:58 PM Eastern
Extended Trading
$12.21 -0.32 (-2.51%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Aimei Health Technology Stock (NASDAQ:AFJK)

Advanced

Key Stats

Today's Range
$12.00
$12.45
50-Day Range
$11.74
$12.56
52-Week Range
$6.75
$130.37
Volume
3,274 shs
Average Volume
29,675 shs
Market Capitalization
$39.70 million
P/E Ratio
200.01
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Aimei Health Technology Co., Ltd. (NASDAQ: AFJK) is a special purpose acquisition company (SPAC). Rather than operating a traditional health-care business, the company was established to identify and complete a merger, acquisition, or similar business combination with an operating company.

The company’s stated focus is expected to include businesses in the health-care and health-technology sectors. Before completing a transaction, Aimei Health Technology does not have a broad portfolio of products or services and may have limited operating activity beyond pursuing a suitable target and managing its corporate structure.

Aimei Health Technology is incorporated in the Cayman Islands and trades in the United States. Publicly available information about its management, geographic operations and any completed business combination is limited.

AI Generated. May Contain Errors.

Aimei Health Technology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
3rd Percentile Overall Score

AFJK MarketRank™: 

Aimei Health Technology scored higher than 3% of companies evaluated by MarketBeat, and ranked 253rd out of 253 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aimei Health Technology has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Aimei Health Technology has only been the subject of 1 research reports in the past 90 days.

  • Read more about Aimei Health Technology's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aimei Health Technology is 208.78, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.14.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aimei Health Technology is 208.78, which means that it is trading at a more expensive P/E ratio than the Energy sector average P/E ratio of about 20.86.

  • Percentage of Shares Shorted

    0.08% of the float of Aimei Health Technology has been sold short.
  • Short Interest Ratio / Days to Cover

    Aimei Health Technology has a short interest ratio ("days to cover") of 0.24, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aimei Health Technology has recently increased by 11.60%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Aimei Health Technology does not currently pay a dividend.

  • Dividend Growth

    Aimei Health Technology does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Aimei Health Technology this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for AFJK on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aimei Health Technology insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.50% of the stock of Aimei Health Technology is held by insiders.

  • Percentage Held by Institutions

    45.58% of the stock of Aimei Health Technology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Aimei Health Technology's insider trading history.
Receive AFJK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aimei Health Technology and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AFJK Stock News Headlines

Aimei Health Technology (NASDAQ:AFJK) Raised to "Sell" at Wall Street Zen
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.tc pixel
Aimei Health Extends SPAC Deadline, Issues New Note
Aimei Health Technology Co., Ltd
Aimei Health Technology Delays Annual 10-K Filing
See More Headlines

AFJK Stock Analysis - Frequently Asked Questions

Aimei Health Technology's stock was trading at $64.01 at the start of the year. Since then, AFJK shares have decreased by 80.4% and is now trading at $12.5250.

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) issued its quarterly earnings data on Thursday, August, 13th. The company reported ($0.03) EPS for the quarter.

Shares of AFJK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/13/2026
Today
9/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Energy
Industry
Oil, Gas & Consumable Fuels
Sub-Industry
Coal & Consumable Fuels
Current Symbol
NASDAQ:AFJK
Previous Symbol
NASDAQ:AFJK
CIK
1979005
Web
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.06
Trailing P/E Ratio
208.78
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.06 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-10.19%
Return on Assets
2.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.01
Quick Ratio
0.01

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.52 per share
Price / Cash Flow
24.27
Book Value
($1.91) per share
Price / Book
-6.56

Miscellaneous

Outstanding Shares
3,170,000
Free Float
3,087,000
Market Cap
$39.70 million
Optionable
N/A
Beta
0.85
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (NASDAQ:AFJK) was last updated on 9/22/2026 by MarketBeat.com Staff.
From Our Partners